Atlas Trials

High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients

Clinical trial NCT05280158 · TERMINATED

Trial details

NCT number
NCT05280158
Sponsor
University of California, Los Angeles
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lung Transplant RecipientSARS-CoV-2Immunosuppression
Start date
2022-03-10
Primary completion
2023-02-27
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.